Acute Basophilic Leukemia with t(8;21)

Tulika Seth(Manipal Academy of Higher Education), Vinod Kochupillai(DR. B.R.A. Institute Rotary Cancer Hospital), Rajive Kumar(DR. B.R.A. Institute Rotary Cancer Hospital), K. Ganessan(DR. B.R.A. Institute Rotary Cancer Hospital), Amish Vora(DR. B.R.A. Institute Rotary Cancer Hospital), Manisha Bhutani(Carolinas Healthcare System), Paresh Jain(DR. B.R.A. Institute Rotary Cancer Hospital)
Leukemia & lymphoma/Leukemia and lymphoma
December 30, 2003
10.1080/10428190310001598053
Cited by 18

Related Papers

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
|The Lancet|2021|321
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
|JAMA Oncology|2015|309
Platelet activation determines the severity of thrombocytopenia in dengue infection
|Scientific Reports|2017|198
Autologous stem cell transplantation in refractory Asherman′s syndrome: A novel cell based therapy
|Journal of Human Reproductive Sciences|2014|184